Compare CORT & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | AM |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 2001 | 2017 |
| Metric | CORT | AM |
|---|---|---|
| Price | $114.23 | $22.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $96.50 | $22.50 |
| AVG Volume (30 Days) | 1.2M | ★ 2.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | N/A | ★ 3.61 |
| EPS | 0.09 | ★ 0.48 |
| Revenue | $761,407,000.00 | ★ $1,188,426,000.00 |
| Revenue This Year | $26.08 | $4.84 |
| Revenue Next Year | $26.98 | $7.05 |
| P/E Ratio | $1,228.89 | ★ $46.02 |
| Revenue Growth | ★ 12.79 | 7.43 |
| 52 Week Low | $28.66 | $16.96 |
| 52 Week High | $122.21 | $23.84 |
| Indicator | CORT | AM |
|---|---|---|
| Relative Strength Index (RSI) | 64.64 | 56.49 |
| Support Level | $76.41 | $22.23 |
| Resistance Level | $122.21 | $23.23 |
| Average True Range (ATR) | 5.13 | 0.51 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 75.23 | 97.97 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.